13D/13G Filings - Deep Track Biotechnology Master Fund, Ltd.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...9, 10, 11, 12, 13
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-05-14
4:05 pm
Purchase
2021-05-1413GMagenta Therapeutics, Inc.
MGTA
Deep Track Biotechnology Master Fund, Ltd.4,155,555
7.140%
4,155,555increase
(New Position)
Filing
History
2021-04-22
5:56 pm
Purchase
2021-04-1913GCrinetics Pharmaceuticals, Inc.
CRNX
Deep Track Biotechnology Master Fund, Ltd.1,898,666
5.050%
1,898,666increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...9, 10, 11, 12, 13